PMC:7152526 / 13004-13182 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7152526","sourcedb":"PMC","sourceid":"7152526","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7152526","text":"Besides, in vivo studies showed that the effects of neutralizing antibodies were not only limited to viral clearance, but also included acceleration of infected cell clearance.15","tracks":[{"project":"LitCovid-PubTator","denotations":[{"id":"317","span":{"begin":152,"end":160},"obj":"Disease"}],"attributes":[{"id":"A317","pred":"tao:has_database_id","subj":"317","obj":"MESH:D007239"},{"subj":"317","pred":"source","obj":"LitCovid-PubTator"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}]},{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T88","span":{"begin":161,"end":165},"obj":"Body_part"}],"attributes":[{"id":"A88","pred":"fma_id","subj":"T88","obj":"http://purl.org/sig/ont/fma/fma68646"},{"subj":"T88","pred":"source","obj":"LitCovid-PD-FMA-UBERON"}]},{"project":"LitCovid-PD-CLO","denotations":[{"id":"T138","span":{"begin":161,"end":165},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"attributes":[{"subj":"T138","pred":"source","obj":"LitCovid-PD-CLO"}]},{"project":"LitCovid-sentences","denotations":[{"id":"T102","span":{"begin":0,"end":178},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T102","pred":"source","obj":"LitCovid-sentences"}]},{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T214","span":{"begin":65,"end":75},"obj":"GO:0042571"},{"id":"T215","span":{"begin":101,"end":106},"obj":"NCBITaxon:10239"},{"id":"T216","span":{"begin":161,"end":175},"obj":"GO:0043277"},{"id":"T43247","span":{"begin":65,"end":75},"obj":"GO:0042571"},{"id":"T64800","span":{"begin":101,"end":106},"obj":"NCBITaxon:10239"},{"id":"T6672","span":{"begin":161,"end":175},"obj":"GO:0043277"}],"attributes":[{"subj":"T214","pred":"source","obj":"LitCovid-PMC-OGER-BB"},{"subj":"T215","pred":"source","obj":"LitCovid-PMC-OGER-BB"},{"subj":"T216","pred":"source","obj":"LitCovid-PMC-OGER-BB"},{"subj":"T43247","pred":"source","obj":"LitCovid-PMC-OGER-BB"},{"subj":"T64800","pred":"source","obj":"LitCovid-PMC-OGER-BB"},{"subj":"T6672","pred":"source","obj":"LitCovid-PMC-OGER-BB"}]},{"project":"2_test","denotations":[{"id":"32281317-27199430-61647294","span":{"begin":176,"end":178},"obj":"27199430"}],"attributes":[{"subj":"32281317-27199430-61647294","pred":"source","obj":"2_test"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PubTator","color":"#93ecdd","default":true},{"id":"LitCovid-PD-FMA-UBERON","color":"#ecc393"},{"id":"LitCovid-PD-CLO","color":"#a993ec"},{"id":"LitCovid-sentences","color":"#96ec93"},{"id":"LitCovid-PMC-OGER-BB","color":"#ec93b1"},{"id":"2_test","color":"#93cbec"}]}]}}